Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG …
M Roach III, G Hanks, H Thames Jr… - International Journal of …, 2006 - Elsevier
In 1996 the American Society for Therapeutic Radiology and Oncology (ASTRO) sponsored
a Consensus Conference to establish a definition of biochemical failure after external beam …
a Consensus Conference to establish a definition of biochemical failure after external beam …
Sarcopenia with limited mobility: an international consensus
JE Morley, AM Abbatecola, JM Argiles… - Journal of the American …, 2011 - Elsevier
A consensus conference convened by the Society of Sarcopenia, Cachexia and Wasting
Disorders has concluded that “Sarcopenia, ie, reduced muscle mass, with limited mobility” …
Disorders has concluded that “Sarcopenia, ie, reduced muscle mass, with limited mobility” …
Potential Glucosamine‐Warfarin interaction resulting in increased international normalized ratio: Case report and review of the literature and MedWatch database
JF Knudsen, GH Sokol - Pharmacotherapy: The Journal of …, 2008 - Wiley Online Library
We describe a 71‐year‐old man who had received warfarin 7.5 mg/day for 5 years for atrial
fibrillation, which had maintained his international normalized ratio (INR) within a narrow …
fibrillation, which had maintained his international normalized ratio (INR) within a narrow …
Systemic therapy for bone metastases
LS Loftus, S Edwards-Bennett, GH Sokol - Cancer Control, 2012 - journals.sagepub.com
Background Accelerated bone loss in patients with cancer is a frequent problem that may
result from invasion of the cancer to bone, paraneoplastic tumor proteins, and/or hormonal …
result from invasion of the cancer to bone, paraneoplastic tumor proteins, and/or hormonal …
US Food and Drug Administration drug approval summaries: imatinib mesylate, mesna tablets, and zoledronic acid
MH Cohen, R Dagher, DJ Griebel, A Ibrahim… - The …, 2002 - academic.oup.com
The purpose of this report is to summarize information on drugs recently approved by the US
Food and Drug Administration. Three drugs have recently been approved …
Food and Drug Administration. Three drugs have recently been approved …
The cyclooxygenase-2 inhibitor celecoxib is a potent inhibitor of human carbonic anhydrase II
JF Knudsen, U Carlsson, P Hammarström, GH Sokol… - Inflammation, 2004 - Springer
Abstract Cyclooxygenase-2 (COX-2) is up-regulated in stromal and inflammatory cells. The
inducible COX-2 isoform is expressed during inflammation, in some cancers, and in brain …
inducible COX-2 isoform is expressed during inflammation, in some cancers, and in brain …
Intraoperative radiotherapy for early breast cancer and age: clinical characteristics and outcomes
Background Eligibility criteria for intraoperative radiation therapy (IORT) for breast cancer
are being established. Impact of age, one criterion, on short-term complications/outcomes …
are being established. Impact of age, one criterion, on short-term complications/outcomes …
Breast cancer survivorship: Patient characteristics and plans for high-quality care.
LS Loftus, GH Sokol, C Laronga - Southern Medical Journal, 2017 - europepmc.org
The number of breast cancer survivors has increased and this increase is expected to
continue, likely as a result of population and age growth, the implementation of earlier …
continue, likely as a result of population and age growth, the implementation of earlier …
On the causes and ramifications of multi-authorship in science
VY Kuperman, GH Sokol - Scientometrics, 2024 - Springer
The objective of this work is to elucidate the causes and ramifications of multi-authorship in
science by surveying researchers working in the field of Medical Physics. During the first 6 …
science by surveying researchers working in the field of Medical Physics. During the first 6 …
[HTML][HTML] Phase II trial of SM-88, a cancer metabolism based therapy, in non-metastatic biochemical recurrent prostate cancer
BA Gartrell, M Roach, A Retter, GH Sokol… - Investigational new …, 2021 - Springer
Background Androgen deprivation therapy (ADT) is a standard treatment for high-risk
biochemically-recurrent, non-metastatic prostate cancer (BRPC) but is not curative and …
biochemically-recurrent, non-metastatic prostate cancer (BRPC) but is not curative and …